An underground market for unapproved weight-loss medications is being driven by social media fitness personalities and sellers on messaging platforms, according to new investigations.
Investigational Drug Gaining Traction Online
The experimental drug, which is still in clinical trials, is being promoted by online personalities for its alleged fat-burning properties. Viewers are encouraged to contact these accounts directly for supplier links, while also obtaining promotional offers.
Active Trade on Messaging Platforms
Separately, a robust trade exists on Telegram, where groups with numerous of participants share comparison photos, injection guides and claims of next-day UK delivery. Sellers promote the substance there before redirecting buyers to WhatsApp for transactions.
Understanding Retatrutide
Retatrutide is an experimental injectable developed by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help individuals reduce up to 25% of their total weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.
Medical Experts Voice Concerns
Nevertheless, doctors and pharmacists have warned that the distribution of what remains an unapproved drug in the UK is a cause for concern and could result in users injecting products of unknown origin.
Several experts said the popularity for the experimental drug could be linked to the rising cost of licensed slimming treatments such as Mounjaro.
Regulatory Status and Enforcement
Marketing the unapproved drug on social media or Telegram is illegal in the United Kingdom, as it is an unapproved medication that must not be promoted or distributed for personal consumption under the British medical regulations.
Some influencers attempt to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and distribution can still breach medicines, marketing, and customer regulations, risking penalties, prosecution or imprisonment.
Platform Response and Content Removal
According to the social media company, the service has removed violative content and banned associated keywords and query recommendations. The company said it was committed to keeping the service secure and allocating resources in strengthening compliance measures.
Online Trading Operations
Investigations also found communities with up to nine thousand participants selling the experimental drug using Telegram's built-in discovery tool, which functions like a public directory. Entering “retatrutide” instantly brings up groups with numerous of users, populated with photos of slimming results, glowing reviews and detailed instructions for preparing or injecting at residence.
After moments of entering one community, a seller posted WhatsApp details, where most transactions take place. The seller provided an guidebook and promised delivery within 48 hours. When asked whether the product was authentic, one vendor responded: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. None inquired about weight, health issues or previous experience.
Item Details and Costs
Inside these communities, messages show dark colored parcels with Royal Mail labels, stating to include fresh supplies. One communication read: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, mixed at home with sterile water, or pre-filled injectors typically priced at £160 for 20mg. When questioned how long a injector should last, vendors give conflicting responses varying between a several days to “depends on your body”.
Service Oversight and Security Measures
A spokesperson for Telegram stated it actively monitored harmful content on its service including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Medical Professional Cautions
“Individuals are administering substances they can’t verify. Even if the science behind this drug is valid, these digital products may not contain what they advertise,” stated Jason Murphy, the director of pharmacy at a pharmacy service.
Dr Crystal Wyllie of an online medical service connected the surge in demand to current price rises for authorized slimming medications such as Mounjaro. “With costs increasing, individuals are using online platforms. But counterfeit treatments are extremely dangerous. You cannot know what’s inside or whether the conditions they were made in was clean,” she explained.
Her staff has previously seen patients injured by personal administration from unverified suppliers. “We understand the disappointment, but buying from Telegram or WhatsApp is taking chances with your health,” stated Wyllie. “These substances could be contaminated or improperly measured.”
Manufacturer Statement
A spokesperson from Eli Lilly stated the substance was in third stage clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this time no one can market [it] for human use,” they said, noting that any product “misleadingly claiming itself as a company experimental product not yet approved … may expose patients to possibly serious medical dangers”.
